Remodulin® to Oral Treprostinil Transition

Clinical trial NCT01588405 · COMPLETED

Trial details

NCT number: NCT01588405
Sponsor: United Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2012-04-01
Primary completion: 2014-07-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.